Terms: = Liver cancer AND ARHGEF12, Q9NZN5, 23365, ENSG00000196914, KIAA0382, LARG, DKFZp686O2372, PRO2792 AND Prognosis
1 results:
1. Inhibition of RhoGEF/RhoA alleviates regorafenib resistance and cancer stemness via Hippo signaling pathway in hepatocellular carcinoma.
Zhou HM; Chen DH; Diao WJ; Wu YF; Zhang JG; Zhong L; Jiang ZY; Zhang X; Liu GL; Li Q
Exp Cell Res; 2024 Mar; 436(1):113956. PubMed ID: 38341081
[TBL] [Abstract] [Full Text] [Related]
